Medicines

  • Dimdazenil Capsules Approved for Marketing by China NPMA for Short Term Treatment of Insomnia Disorders

    Nov, 2023. Class 1 innovative drug Dimdazenil Capsules from Zhejiang Jingxin Pharmaceutical Co., Ltdis approved for marketing by China NPMA for short term treatment of insomnia disorders.

    2023-11-30
  • Jemincare’s Palbociclib Capsules and API Approved for Marketing by China NPMA

    Nov,2023. Jiangxi Ashter Pharmaceutical Co Ltd, branch company of Jemincare, get the drug registration licence for Palbociclib Capsules 75mg, 100mg and 150mg for the treatment of breast cancer. Palbociclib API of Jemincare group get the licence in Nov, 2023 as well.

    2023-11-28
  • Pipetting Tips for Different Special Types of Sample

    For occasionally pipetting of special samples, Here are Pipetting Tips for Different Special Types of Sample.

    2023-11-17
  • Aponermin for Injection of Wuhan HITECK approved by China NPMA for Multiple Myeloma

    Aponermin for Injection (Brand Name:SHAAITE) of Wuhan HITECK biopharmaceutical Co., Ltd. is approved for marketing by China NMPA, which is used in combination with thalidomide and dexamethasone for the treatment of adult patients with relapsed or refractory Multiple Myeloma after two or more systemic therapies.

    2023-11-07
  • 6 useful methods to clean GC/LC sampling bottles

    Sample bottle has a great impact on the chromatographic analysis process and results. If the sample bottle is not cleaned cleanly, it may cause: ghost peaks, sample degradation, analyte loss, poor injection repeatability etc, which might lead to deviations in the experimental results.

    2023-11-07
  • Guidelines to Improve Repeatability of Gas Chromatography

    While using a gas chromatograph for analysis, good quantitative repeatability is very important. However, repeatability often occurs during the experiment. Which components have problems that will lead to poor repeatability of the analysis results? Let’s discuss it here.

    2023-11-03
  • Skyline Therapeutics’s SKG0106 Approved by NMPA for Clinical Trials

    October 2023 , Skyline Therapeutics announced that the clinical trial application (IND) of SKG0106 is approved by the China National Medical Products Administration (NMPA) for the treatment of neovascular age-related macular degeneration (nAMD). SKG0106 was approved by the U.S. Food and Drug Administration (FDA) earlier this year to conduct a global Phase I/IIa clinical trial for the treatment of neovascular age-related macular degeneration (nAMD). The global clinical trial has been launched. SKG0106 is a distinctively designed recombinant adeno-associated virus (rAAV)-mediated gene therapy for ocular disease. It encompasses a proprietary novel…

    2023-10-21
  • Narlumosbart for Injection approved with conditions for marketing by China NMPA

    Sep, 2023. the class 1 new drug Narlumosbart for Injection(JMT103) developed by Shanghai JMT-Bio Technology Co. Ltd is approved by China NMPA . This drug is indicated for the treatment for adult patients with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity. Narlumosbart Injection is a recombinant human anti-receptor activator of NF-κB ligand (RANKL) monoclonal antibody. It can inhibit the activity of RANKL through specifically binding to RANKL on the cell membrane, thereby inhibiting its involvement in mediating osteolysis…

    2023-09-20
  • Sunvozertinib Tablets Approved in China for NSCLC by China NMPA

    Aug, 2023. China NMPA approved the Category 1 innovative drug Sunvozertinib Tablets (Chinese trade name:SHUWUZHE) of Dizal (Jiangsu) Pharmaceutical Co., Ltd for use in adult patients with locally advanced or metastatic non–small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion mutations whose disease has progressed on or following platinum-based chemotherapy. Non-small cell lung cancer (NSCLC) is the most common type of cancer in China, with the highest incidence and mortality rates. EGFR is the most common driver gene mutation in NSCLC, and the EGFR Exon20ins mutation is the most…

    2023-08-29
  • 6 Factors that Cause Liquid Chromatography Peak Diffusion

    The main differences gas chromatography (GC) and liquid chromatography (LC) are primarily due to the differences in the properties of gas and liquid.Below are 6 Factors that mainly Cause Liquid Chromatography Peak Diffusion.

    2023-07-19